Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ABBV · against 7 other Healthcare companies of similar size
Ranked #8 of 8 · scores higher than 0% of peers · safety percentile 9
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)1 peers with a safety percentile of 0–9, including ABBV · Click a bar to see the companies
Mainly because of its debt / equity and current ratio, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ABBV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 7 reported | Not reported | 0.81× | — | — | 33% |
| BetaLower is better · 8 reported | 0.23 | 0.29 | 57% | 33% | |
| Current ratioHigher is better · 8 reported | 0.81× | 1.05× | 14% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 641.4B USD | 39 | 59 | |
| 2 | 285.2B USD | 35 | 63 | |
| 3 | 302.7B USD | 31 | 63 | |
| 4 | 317.9B CHF (≈$365.6B) | 25 | 60 | |
| 5 | 363.0B USD | 25 | 47 | |
| 6 | 258.2B USD | 22 | 47 | |
| 7 | 356.9B USD | 19 | 37 | |
| 8 | 505.4B USD | 9 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score